Ivonescimab HARMONi-6 Results Selected for ESMO 2025 LBA; Final Phase III Results of Cadonilimab as First-Line Therapy for Advanced Gastric Cancer to Be Published as an Oral Presentation

prnewswire

Ivonescimab HARMONi-6 Results Selected for ESMO 2025 LBA; Final Phase III Results of Cadonilimab as First-Line Therapy for Advanced Gastric Cancer to Be Published as an Oral Presentation – NEWSnet – News… as it used to be

More Press Releases

May 10, 2026

Ferrari Club Israel And Ran Tottnauer Host Inspirational Morning at Shalva National Center

May 10, 2026

RECORD BREAKERS FOUNDER COLBY RAHA WILL ATTEMPT WORLD-RECORD MOTORCYCLE JUMP MAY 17 AT OMNIA DAYCLUB AT CAESARS PALACE’S

May 10, 2026

Oceania Renee Makes Appearance at Amare Magazine Cover Release Event

May 10, 2026

Ivonescimab HARMONi-6 Results Selected for ESMO 2025 LBA; Final Phase III Results of Cadonilimab as First-Line Therapy for Advanced Gastric Cancer to Be Published as an Oral Presentation

Ferrari Club Israel And Ran Tottnauer Host Inspirational Morning at Shalva National Center

RECORD BREAKERS FOUNDER COLBY RAHA WILL ATTEMPT WORLD-RECORD MOTORCYCLE JUMP MAY 17 AT OMNIA DAYCLUB AT CAESARS PALACE’S

Oceania Renee Makes Appearance at Amare Magazine Cover Release Event

RiskMail.io Launches Disposable Email Detection API to Help Businesses Block Fake Signups